Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.42 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.35 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.33 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | PARP1 | P09874 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL599552 | 1.00 | ALDH1A1 (0.42) | ALDH1A1HCAR2HTTEGLN1KDM4E | |
| SCHEMBL7771328 | 1.00 | ALDH1A1 (0.42) | ALDH1A1HCAR2HTTEGLN1KDM4E | |
| Fumaric Acid SCHEMBL29989236 | 0.93 | HCAR2 (0.50) | ALDH1A1HCAR2HTTEGLN1KDM4E | |
| Acetic Acid SCHEMBL27317270 | 0.82 | ALDH1A1 (0.40) | ALDH1A1HCAR2EGLN1KDM4EMAPT | |
| SCHEMBL623254 | 0.81 | HTT (0.36) | ALDH1A1HTTKDM4EMAPTCYP1A2 | |
| SCHEMBL7037263 | 0.81 | ALDH1A1 (0.43) | ALDH1A1HCAR2EGLN1KDM4EMAPT | |
| SCHEMBL28023754 | 0.81 | ALDH1A1 (0.43) | ALDH1A1HCAR2EGLN1KDM4EMAPT | |
| SCHEMBL14749991 | 0.81 | ALDH1A1 (0.43) | ALDH1A1HCAR2EGLN1KDM4EMAPT | |
| SCHEMBL20025 | 0.81 | HTT (0.36) | ALDH1A1HTTKDM4EMAPTCYP1A2 | |
| SCHEMBL12065716 | 0.81 | ALDH1A1 (0.43) | ALDH1A1HCAR2EGLN1KDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 323 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210161851-A1 | COMBINATION THERAPY OF LYMPHOMA | DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) | 2021-06-03 | — | — | US | claimed |
| EP-2900815-B1 | METHODS AND TOOLS FOR IDENTIFICATION OF RSK/MSK KINASE INHIBITORS | UNIV AARHUS (DK) | 2017-06-21 | — | — | EP | claimed |
| EP-0601754-B1 | Vinylidene fluoride copolymer, and binder composition containing the copolymer for non-aqueous solvent type secondary battery | KUREHA CHEMICAL IND CO LTD (JP) | 1998-01-21 | — | — | EP | claimed |
| US-5534341-A | LOFTED NON-WOVEN MATERIAL; FIREPROOFING | UNILEVER PATENT HOLDINGS BV (NL) | 1996-07-09 | — | — | US | claimed |
| US-5415958-A | Monoester of unsaturated diacid copolymers | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1995-05-16 | — | — | US | claimed |
| EP-0601754-A1 | Vinylidene fluoride copolymer, and binder composition containing the copolymer for non-aqueous solvent type secondary battery | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1994-06-15 | — | — | EP | claimed |
| EP-0269274-B1 | Process for the preparation of thermoplastic elastomer compositions | MITSUI PETROCHEMICAL IND (JP) | 1993-12-15 | — | — | EP | claimed |
| EP-0266982-A2 | Laminated and molded article prepared therefrom | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1988-05-11 | — | — | EP | claimed |
| JP-11130821-A | — | — | None | — | — | JP | disclosed |
| JP-6172452-A | — | — | None | — | — | JP | disclosed |
| US-12609414-B2 | Non-aqueous secondary battery | TEIJIN LIMITED (JP) | 2026-04-21 | — | — | US | disclosed |
| EP-4414420-B1 | VINYLIDENE FLUORIDE POLYMER SOLUTION | KUREHA CORP (JP) | 2026-04-08 | — | — | EP | disclosed |
| US-12594259-B2 | Treatment regimen for the treatment of neurological diseases or conditions | ACCURE THERAPEUTICS, S.L. (ES) | 2026-04-07 | — | — | US | disclosed |
| US-20260076940-A1 | TREATMENT REGIMEN FOR THE TREATMENT OF NEUROLOGICAL DISEASES OR CONDITIONS | ACCURE THERAPEUTICS, S.L. (ES) | 2026-03-19 | — | — | US | disclosed |
| EP-0226055-A1 | Carboxylated phenylene ether resins | GE CHEMICALS, INC. (US) | 1987-06-24 | — | — | EP | disclosed |
| EP-0219548-A1 | POLYOLEFIN FOAM COMPOSITIONS HAVING IMPROVED DIMENSIONAL STABILITY UTILIZING CERTAIN UNSATURATED NITROGEN-CONTAINING COMPOUNDS ANDPROCESS FOR MAKING SAME. | DOW CHEMICAL CO (US) | 1987-04-29 | — | — | EP | disclosed |
| WO-1986007076-A1 | POLYOLEFIN FOAM COMPOSITIONS HAVING IMPROVED DIMENSIONAL STABILITY UTILIZING CERTAIN UNSATURATED NITROGEN-CONTAINING COMPOUNDS ANDPROCESS FOR MAKING SAME | THE DOW CHEMICAL COMPANY (US) | 1986-12-04 | — | — | WO | disclosed |
| US-4203996-A | Synthetic cephalotaxine esters having antileukemic P388 activity | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 1980-05-20 | — | — | US | disclosed |
| US-4152333-A | ALKALOIDS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 1979-05-01 | — | — | US | disclosed |
| US-4013524-A | Electrolytic carboxylation and dimerization of olefins | MONSANTO COMPANY (US) | 1977-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210161851-A1 | COMBINATION THERAPY OF LYMPHOMA | IKBKB, NFKBIA, BCL3 | ALDH1A1 1296/4885HCAR2 973/4885HTT 4426/4885 |
| US-12594259-B2 | Treatment regimen for the treatment of neurological diseases or conditions | PMP22, SMN1; SMN2, MYT1 | ALDH1A1 622/4885HCAR2 2345/4885HTT 94/4885 |
| US-12609414-B2 | Non-aqueous secondary battery | SLC9A2, SLC9A1, TAF9 | ALDH1A1 3694/4885HCAR2 4842/4885HTT 3082/4885 |
| US-20260076940-A1 | TREATMENT REGIMEN FOR THE TREATMENT OF NEUROLOGICAL DISEASES OR CONDITIONS | AQP4, SCN10A, PMP22 | ALDH1A1 3076/4885HCAR2 3652/4885HTT 1069/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.